跳至主要内容
临床试验/NCT03325725
NCT03325725撤回不适用

Intra-laryngeal Implant for Treatment of Chronic Aspirations

ProTiP Medical4 个研究点 分布在 1 个国家开始时间: 2018年1月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
4
主要终点
Sealing of the NewBreez LD: Protection of the lower airways will be assessed using the gold standard exam, videofluoroscopy (VFS)

研究概览

简要总结

This study evaluates the medical device Newbreez LD is designed to protect the lower airways from saliva, liquids and food aspirations in tracheotomized patients suffering from chronic aspirations that require specific care and may lead to complications, including inhalation pneumonia.

详细描述

Patients suffering from swallowing disorders characterized by chronic aspirations (repeated episodes of aspirations defined as penetration of material - liquids, food, saliva, into the respiratory system due to a malfunctioning of the swallowing mechanism) are subject to pathologies and pulmonary insufficiencies. The risks of aspiration pneumonia or suffocation are significantly greater if the patient is not able to expectorate and thus engages the vital prognosis. There are several methods to treat chronic aspirations: the least invasive methods involve adopting postures and/or positions of the body during swallowing and adapting food textures; when these treatments are insufficient there is the need to recur to more advanced ones to protect the airways and keep the patient on a sufficient nutrition.

For these severe cases, heavier surgical methods can be also considered. These methods lead to important anatomical changes, with a variable degree of reversibility, up to irreversibility (eg total laryngectomy). Among surgical methods, there is also an implant of a tracheotomy cuffed cannula that allows patient to breathe through a hole in the trachea. The efficacy of this solution is highly controversial as reported by numerous studies and several adverse effects are reported on the tracheal duct.

Due to the interest of a prosthetic treatment and the disadvantages of the current methods and devices, PROTiP Medical has developed a closed intra-laryngeal implant: NewBreez LD. This device is innovative because its geometry has been optimized to conform totally to the anatomy of the larynx with the aim to ensure a sealing against saliva, liquids and food aspirations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Swallowing disorders characterized by chronic aspirations;
  • Tracheotomy performed, inter alia, in the management of swallowing disorders;
  • Aged over 18;
  • Willing and able to comply with the requirements of the study;
  • Informed consent signed;
  • Affiliated patient or beneficiary of the social security system.

排除标准

  • Do not implant in patients with incomplete cricoid cartilage (surgery or other);
  • Do not implant in patients with tracheotomy performed by cricothyroidectomy or between cricoid cartilage and the 1st tracheal ring;
  • Do not implant in patients with tracheal lumen in the 1st tracheal ring, the lateral and anteroposterior diameters of which are less than 11 mm;
  • Do not implant in patients with tight trismus;
  • Do not implant in subjects less than 18 years of age;
  • Do not implant in patients with bleeding disorders;
  • Do not implant in patients contraindicated to general anesthesia.

研究组 & 干预措施

NewBreez LD Intra-laryngeal implant

Experimental

干预措施: NewBreez LD intra-laryngeal implant (Device)

结局指标

主要结局

Sealing of the NewBreez LD: Protection of the lower airways will be assessed using the gold standard exam, videofluoroscopy (VFS)

时间窗: 7 days

Protection of the lower airways will be assessed using the gold standard exam, videofluoroscopy (VFS)

次要结局

未报告次要终点

研究者

发起方
ProTiP Medical
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验